Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Bulgaria

European Innovation Council · Running

VMS - Vaginal Microbiome Screening Commercialisation and scale up of a Vaginal Microbiome Screening service with a menstrual tampon collection device and a digital layer to provide diagnosis, disease risk evaluation and aftercare.

Coordinator
Tamponeni Inovatsii Ood, Bulgaria
Runs
1 July 2023 to 30 June 2025
Status
Running
EU funding
€2.5m
Total cost
€3.8m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190192897

What the project is doing

In the project's own words, from its summary on CORDIS.

VMS is a home-based gynaecological test kit, using a menstrual tampon for sample collection. VMS will improve the accuracy and convenience with which STI, vaginal infections and HPV screening is undertaken. Daye has patented the proprietary protocol for DNA extraction from a tampon for PCR analysis, testing for 16 different factors at a time. VMS can be used to detect vaginal dysbiosis, HPV and STIs, like chlamydia, gonorrhea and trichomoniasis.

Vaginal microbiome screening with VMS will unlock invaluable insights into our customers’ vaginal health. There’s a direct correlation between vaginal microbiome health and the likelihood of contracting an STI, developing a gynecological cancer, experiencing fertility and pregnancy challenges, as well as susceptibility to recurrent vaginal and urethral infections. Post screen, VMS will offer comprehensive aftercare, including prescriptions, doctor consultations, booking in-person visits, and vaginal microbiome enhancement plan with probiotics

Topics

Who is involved

OrganisationCityCountryRole
Tamponeni Inovatsii OodSofiaBulgariaCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI